- Home
- FE vs BDTX Comparison
FE vs BDTX Comparison
Compare FE & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- BDTX
- Stock Information
- Founded
- FE 1996
- BDTX 2014
- Country
- FE United States
- BDTX United States
- Employees
- FE N/A
- BDTX N/A
- Industry
- FE Electric Utilities: Central
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FE Utilities
- BDTX Health Care
- Exchange
- FE Nasdaq
- BDTX Nasdaq
- Market Cap
- FE N/A
- BDTX 132.5M
- IPO Year
- FE N/A
- BDTX 2020
- Fundamental
- Price
- FE $40.43
- BDTX $2.94
- Analyst Decision
- FE Buy
- BDTX Strong Buy
- Analyst Count
- FE 15
- BDTX 6
- Target Price
- FE $46.15
- BDTX $14.83
- AVG Volume (30 Days)
- FE 4.3M
- BDTX 1.2M
- Earning Date
- FE 07-30-2025
- BDTX 08-05-2025
- Dividend Yield
- FE 4.40%
- BDTX N/A
- EPS Growth
- FE 1.45
- BDTX N/A
- EPS
- FE 1.88
- BDTX 0.09
- Revenue
- FE $13,764,000,000.00
- BDTX $70,000,000.00
- Revenue This Year
- FE $9.20
- BDTX N/A
- Revenue Next Year
- FE $3.82
- BDTX N/A
- P/E Ratio
- FE $21.50
- BDTX $33.49
- Revenue Growth
- FE 8.03
- BDTX N/A
- 52 Week Low
- FE $37.58
- BDTX $1.20
- 52 Week High
- FE $44.97
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- FE 50.10
- BDTX 70.75
- Support Level
- FE $39.34
- BDTX $2.43
- Resistance Level
- FE $40.59
- BDTX $2.72
- Average True Range (ATR)
- FE 0.53
- BDTX 0.18
- MACD
- FE 0.11
- BDTX 0.03
- Stochastic Oscillator
- FE 76.08
- BDTX 93.66
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.